Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-08

Clinical Trial Update: A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines [NA]

View source ↗

Summary

This clinical trial update describes a study to characterize immune responses after immunisation with two Hepatitis B vaccines, Fendrix and Engerix B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Engerix-B (hepatitis B vaccine)
  • Fendrix

Snippet

Sponsor: University of Surrey | Conditions: Hepatitis B | NA | Status: COMPLETED